Daniel R Wahl
Overview
Explore the profile of Daniel R Wahl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1996
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Al-Holou W, Wang H, Ravikumar V, Shankar S, Oneka M, Fehmi Z, et al.
Neoplasia
. 2023 Jan;
36:100872.
PMID: 36621024
Purpose: Glioblastoma(GBM) is a lethal disease characterized by inevitable recurrence. Here we investigate the molecular pathways mediating resistance, with the goal of identifying novel therapeutic opportunities. Experimental Design: We developed...
22.
Bell H, Huber A, Singhal R, Korimerla N, Rebernick R, Kumar R, et al.
Cell Metab
. 2022 Dec;
35(1):134-149.e6.
PMID: 36528023
Effective therapies are lacking for patients with advanced colorectal cancer (CRC). The CRC tumor microenvironment has elevated metabolic waste products due to altered metabolism and proximity to the microbiota. The...
23.
Quinn T, Chapman D, Parzen J, Wahl D, McNamara A, Dess R, et al.
Pract Radiat Oncol
. 2022 Dec;
13(2):e166-e175.
PMID: 36503624
Purpose: Prognostic factors for prostate cancer include tumor, node, metastases stage, pretreatment prostate-specific antigen, and pathology (via Gleason score [GS] or grade group). Of these, GS yields the largest effect...
24.
Laucis A, Selwa K, Sun Y, Kim M, Cuneo K, Lawrence T, et al.
Neurooncol Pract
. 2022 Nov;
9(6):536-544.
PMID: 36388411
Background: There is no consensus on the treatment of central nervous system (CNS) lymphoma refractory to first-line methotrexate-based chemotherapy. Whole brain radiotherapy (WBRT) is sometimes used but may result in...
25.
Halasz L, Attia A, Bradfield L, Brat D, Kirkpatrick J, Laack N, et al.
Pract Radiat Oncol
. 2022 Jul;
12(5):370-386.
PMID: 35902341
Purpose: This guideline provides evidence-based recommendations for adults with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse glioma, as classified in the 2021 World Health Organization (WHO) Classification of...
26.
Wang Y, Zhao W, Bai S, Feng L, Bie S, Gong L, et al.
Nat Commun
. 2022 May;
13(1):2638.
PMID: 35551189
The rapid recognition of DNA double-strand breaks (DSBs) by the MRE11/RAD50/NBS1 (MRN) complex is critical for the initiation of DNA damage response and DSB end resection. Here, we show that...
27.
Korimerla N, Wahl D
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163841
Metabolic reprogramming is a hallmark of cancer. Cancer cells rewire one-carbon metabolism, a central metabolic pathway, to turn nutritional inputs into essential biomolecules required for cancer cell growth and maintenance....
28.
Feng L, Liu Z, Li C, Li Z, Lou X, Shao L, et al.
Lancet Digit Health
. 2021 Dec;
4(1):e8-e17.
PMID: 34952679
Background: Accurate prediction of tumour response to neoadjuvant chemoradiotherapy enables personalised perioperative therapy for locally advanced rectal cancer. We aimed to develop and validate an artificial intelligence radiopathomics integrated model...
29.
Edwards D, Speers C, Wahl D
Semin Radiat Oncol
. 2021 Dec;
32(1):64-75.
PMID: 34861997
No abstract available.
30.
Sweha S, Chung C, Natarajan S, Panwalkar P, Pun M, Ghali A, et al.
Sci Transl Med
. 2021 Oct;
13(615):eabf7860.
PMID: 34644147
High-grade gliomas with arginine or valine substitutions of the histone H3.3 glycine-34 residue (H3.3G34R/V) carry a dismal prognosis, and current treatments, including radiotherapy and chemotherapy, are not curative. Because H3.3G34R/V...